Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2021 2
2022 5
2023 2
2024 2
2025 4
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
COVID-19 knowledge, attitudes, and practices among people vulnerable to HIV in Uganda: A cross-sectional cohort analysis.
Kasule J, Tonzel JL, Burns N, Hamby T, Ying R, Mirembe G, Nakabuye I, Kibuuka H, Yacovone M, Mwesigwa B, Crowell TA; Multinational Observational Cohort of HIV and other Infections (MOCHI) Study Group. Kasule J, et al. Among authors: mwesigwa b. PLoS One. 2026 Mar 3;21(3):e0343507. doi: 10.1371/journal.pone.0343507. eCollection 2026. PLoS One. 2026. PMID: 41774742 Free PMC article.
Patterns and Predictors of HIV Pre-exposure Prophylaxis (PrEP) Continuity Among Young Women Who Sell Sex in Uganda: A Group-Based Trajectory Modeling Approach.
Rosen JG, Rao A, Kibuuka H, Mwesigwa B, Mirembe G, Musingye E, Abdulrahman A, Baral SD, Crowell TA, Akom EE, Rucinski KB. Rosen JG, et al. Among authors: mwesigwa b. AIDS Behav. 2025 Dec 23:10.1007/s10461-025-04993-4. doi: 10.1007/s10461-025-04993-4. Online ahead of print. AIDS Behav. 2025. PMID: 41432870 Free PMC article.
Finding the Sweet Spot: Preferences for Effectiveness, Duration, and Side Effects in a Discrete Choice Experiment Among Uganda's Key Populations.
Ngaybe MGB, Muhumuza R, Antunes M, Musingye E, Joseph KK, Nakaggwa B, Mugamba S, Ssuna B, Valdez G, Ehiri J, Ingram M, Kiragga A, Mirembe G, Mwesigwa B, Kibuuka H, Madhivanan P. Ngaybe MGB, et al. Among authors: mwesigwa b. Vaccines (Basel). 2025 Oct 24;13(11):1090. doi: 10.3390/vaccines13111090. Vaccines (Basel). 2025. PMID: 41295463 Free PMC article.
Africa is an Essential Partner in the Research and Development of an HIV Vaccine.
Gray G, Williamson C, Bekker LG, Daniels B, Smidt W, Garrett N, Kityo Mutuluuza C, Mwesigwa B, Stranix-Chibanda L, Akimbu A, Obuku A, Johnson T, Naluyima P, Sawe F, Burgers W, Ntiginya N, Morar N, Takalani A, Hendricks S, Woeber K, Abrahams F, Tholanah M, Mugamba S, Mulder M, Moore P. Gray G, et al. Among authors: mwesigwa b. Curr HIV Res. 2025 Oct 2. doi: 10.2174/011570162X361496250627004203. Online ahead of print. Curr HIV Res. 2025. PMID: 41047688
Ebola virus vaccination elicits Ebola virus-specific immune responses without substantial cross-reactivity to other filoviruses.
Mdluli T, Wollen-Roberts S, Merbah M, Beckman B, Li Y, Alrubayyi A, Curtis DJ, Shubin Z, Barrera MD, Boeckelman J, Duncan S, Thapa P, Kim D, Costanzo MC, Bai H, Dearlove BL, Hooper JW, Kwilas SA, Paquin-Proulx D, Eller MA, Eller LA, Kibuuka H, Mwesigwa B, Kosgei J, Sawe F, Oyieko J, Ntinginya N, Mwakisisile J, Jani I, Viegas E, Iroezindu M, Akintunde A, Paolino K, Robb ML, Ward L, McLean C, Luhn K, Robinson C, Ake JA, Rolland M. Mdluli T, et al. Among authors: mwesigwa b. Sci Transl Med. 2025 Apr 2;17(792):eadq2496. doi: 10.1126/scitranslmed.adq2496. Epub 2025 Apr 2. Sci Transl Med. 2025. PMID: 40173257
Safety and Immunogenicity of Accelerated Heterologous 2-Dose Ebola Vaccine Regimens in Adults With and Without HIV in Africa.
Mwesigwa B, Sawe F, Oyieko J, Mwakisisile J, Viegas E, Akintunde GA, Kosgei J, Kokogho A, Ntinginya N, Jani I, Shukarev G, Hooper JW, Kwilas SA, Ward LA, Rusnak J, Bounds C, Overman R, Badorrek CS, Eller LA, Eller MA, Polyak CS, Moodley A, Tran CL, Costanzo MC, Leggat DJ, Paquin-Proulx D, Naluyima P, Anumendem DN, Gaddah A, Luhn K, Hendriks J, McLean C, Douoguih M, Kibuuka H, Robb ML, Robinson C, Ake JA. Mwesigwa B, et al. Clin Infect Dis. 2024 Oct 15;79(4):888-900. doi: 10.1093/cid/ciae215. Clin Infect Dis. 2024. PMID: 38657084 Clinical Trial.
Sustaining Functionality of Not-for-Profit Health Organisations During Pandemics: Lessons and COVID 19 Experience from Makerere University Walter Reed Project.
Ssensamba JT, Atwijuka B, Nakimuli S, Kyohangirwe B, Atim G, Musingye E, Bakunda CM, Namugabo J, Naluyima P, Musinguzi A, Mugamba S, Mwesigwa B, Kibuuka H. Ssensamba JT, et al. Among authors: mwesigwa b. East Afr Health Res J. 2024;8(3):315-326. doi: 10.24248/eahrj.v8i3.800. Epub 2025 Jan 30. East Afr Health Res J. 2024. PMID: 40386132 Free PMC article.
HIV-1 Remission: Accelerating the Path to Permanent HIV-1 Silencing.
Lyons DE, Kumar P, Roan NR, Defechereux PA, Feschotte C, Lange UC, Murthy N, Sameshima P, Verdin E, Ake JA, Parsons MS, Nath A, Gianella S, Smith DM, Kallas EG, Villa TJ, Strange R, Mwesigwa B, Furler O'Brien RL, Nixon DF, Ndhlovu LC, Valente ST, Ott M. Lyons DE, et al. Among authors: mwesigwa b. Viruses. 2023 Oct 28;15(11):2171. doi: 10.3390/v15112171. Viruses. 2023. PMID: 38005849 Free PMC article.
Safety, tolerability, and immunogenicity of the Ebola Sudan chimpanzee adenovirus vector vaccine (cAd3-EBO S) in healthy Ugandan adults: a phase 1, open-label, dose-escalation clinical trial.
Mwesigwa B, Houser KV, Hofstetter AR, Ortega-Villa AM, Naluyima P, Kiweewa F, Nakabuye I, Yamshchikov GV, Andrews C, O'Callahan M, Strom L, Schech S, Anne Eller L, Sondergaard EL, Scott PT, Amare MF, Modjarrad K, Wamala A, Tindikahwa A, Musingye E, Nanyondo J, Gaudinski MR, Gordon IJ, Holman LA, Saunders JG, Costner PJM, Mendoza FH, Happe M, Morgan P, Plummer SH, Hickman SP, Vazquez S, Murray T, Cordon J, Dulan CNM, Hunegnaw R, Basappa M, Padilla M, Gajjala SR, Swanson PA 2nd, Lin BC, Coates EE, Gall JG, McDermott AB, Koup RA, Mascola JR, Ploquin A, Sullivan NJ, Kibuuka H, Ake JA, Ledgerwood JE; RV 508 Study Team. Mwesigwa B, et al. Lancet Infect Dis. 2023 Dec;23(12):1408-1417. doi: 10.1016/S1473-3099(23)00344-4. Epub 2023 Aug 3. Lancet Infect Dis. 2023. PMID: 37544326 Free PMC article. Clinical Trial.
17 results